Michigan Medicine is home to the Pranger Amyotrophic Lateral Sclerosis (ALS) Clinic), which provides multidisciplinary care to hundreds of ALS patients each year. Thanks to the collaborative relationship between Michigan Medicine … [Read more...]
Early Treatment with New ALS Drug Combination Improved Survival
An open label extension shows additional benefit from a drug currently being tested for patients with Lou Gehrig’s disease. from the M Health Lab Blog by Haley Otman Follow up data shows that not only did a new drug help slow … [Read more...]
New Drug Combination May Slow Symptom Course Early on in ALS
Positive clinical trial points to a possible additional option for patients with ALS. Dr. Stephen Goutman explains the excitement and the caution. from the M Health Lab Blog by Haley Otman A new drug combination could help … [Read more...]
NeuroNetwork Partners with Mt. Sinai to Discover ALS Biomarkers in Teeth
Drs. Eva Feldman, Stephen Goutman and Claudia Figueroa-Romero collaborated with Mount Sinai to find evidence that early childhood heavy metal exposure is an ALS risk factor. Scientists from the Michigan Medicine NeuroNetwork for … [Read more...]
Taking on ALS: An Emotional and Financial Burden
ALS impacts families like the Prangers mentally, physically and emotionally. Scott Pranger explains how it also can throw a financial curveball, and why he was inspired to help. By Haley Otman, Michigan Medicine … [Read more...]
Multidisciplinary ALS Clinic Rapidly Rolls Out Virtual Care
Physicians and clinicians have quickly adapted Virtual Care to deliver uninterrupted patient care during the stay-at-home directive related to the COVID-19 pandemic. The Multidisciplinary ALS Clinic at Michigan … [Read more...]
Voicing the Need for ALS Environmental Research
Drs. Feldman and Goutman call for action to study how the environment influences ALS risk and progression in a JAMA Neurology article. Dr. Feldman recently received a $2.5 million grant from the NIH to examine the ties between … [Read more...]
Feldman Partners with Reubinoff from Hadassah University in ALS Research
Latest research shows that ALS not only damages motor neurons, but also cells that support neuron function. The work was a collaborative effort with Dr. Benjamin Reubinoff, who is an affiliate member of the NeuroNetwork for … [Read more...]
Promising Results from Clinical Drug Trial Covered by The Wall Street Journal
U-M’s ALS Center of Excellence is a Research Site for the Amylyx Pharmaceuticals Drug Preliminary data showing an Amylyx Pharmaceuticals drug as a promising new therapy in slowing the progression of ALS was published in The Wall … [Read more...]
#ICEALS: Hockey Brings ALS Physicians, Friends Together from Michigan and Penn State
Drs. Eva Feldman and Zach Simmons, who direct the multidisciplinary ALS clinics at U-M, PSU, respectively, discuss their history together and their work in ALS The University of Michigan hockey team will hold its fourth … [Read more...]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 10
- Next Page »